Key facts
- Notable investors include SOSV, IndieBio, Portland Seed Fund, Launch Oregon.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Synplexity
- ·The full record, as it builds
Funding rounds
No funding rounds for Synplexity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synplexity
Operator of a large-scale gene synthesis and proteomics discovery company based in New Castle, Delaware. The company's platform utilizes technology to synthesize genes in microdroplets, which serve as microreactors, enabling the healthcare industry to enable the creation of multiplex gene libraries in therapeutics, biomanufacturing, agriculture, and climate systems.
- Sector
- Healthcare
- HQ
- Eugene, OR, United States
- Founded
- 2024
- Employees
- 3
- Website
- synplexity.com/
- Ownership
- Privately Held (backing)
Synplexity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synplexity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synplexity in its N-PORT filings yet. We sweep new filings monthly.